Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Opposite physiological and pathological mTORC1-mediated roles of the CB1 receptor in regulating renal tubular function
Liad Hinden, Majdoleen Ahmad, Sharleen Hamad, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 18

Showing 18 citing articles:

Inhibition of SGLT2 co-transporter by dapagliflozin ameliorates tubular proteinuria and tubule-interstitial injury at the early stage of diabetic kidney disease
Raysa S. Farias, Rodrigo P. Silva‐Aguiar, Douglas E. Teixeira, et al.
European Journal of Pharmacology (2023) Vol. 942, pp. 175521-175521
Closed Access | Times Cited: 12
Therapeutic potential of a novel peripherally restricted CB1R inverse agonist on the progression of diabetic nephropathy
Laetitia Jacquot, Océane Pointeau, Célia Roger-Villeboeuf, et al.
Frontiers in Nephrology (2023) Vol. 3
Open Access | Times Cited: 12
Kidney and Urinary System
Jean-Paul Henri Dedam, Matthew Fogel, Elizabeth Fogel
(2025), pp. 51-57
Closed Access
A glycopolymersome strategy for ‘drug-free’ treatment of diabetic nephropathy
Jiamin Zhang, Tong Wu, Chang Li, et al.
Journal of Controlled Release (2024) Vol. 372, pp. 347-361
Closed Access | Times Cited: 3
Fufang Zhenzhu Tiaozhi (FTZ) capsule ameliorates diabetic kidney disease in mice via inhibiting the SGLT2/glycolysis pathway
Ziyang Lin, Hongyan Huo, Min-Yi Huang, et al.
Journal of Ethnopharmacology (2024) Vol. 335, pp. 118698-118698
Closed Access | Times Cited: 3
Transcription factor c-Maf deletion improves streptozotocin-induced diabetic nephropathy by directly regulating Sglt2 and Glut2
Mitsunori Fujino, Naoki Morito, Takuto Hayashi, et al.
JCI Insight (2023) Vol. 8, Iss. 6
Open Access | Times Cited: 7
A Retrospective Cohort Study That Examined the Impact of Cannabis Consumption on Long-Term Kidney Outcomes
Joshua L. Rein, Hui Zeng, Georgia Brown Faulkner, et al.
Cannabis and Cannabinoid Research (2023) Vol. 9, Iss. 2, pp. 635-645
Closed Access | Times Cited: 7
The effects of cannabinoids on the kidney
Steven Didik, Oleg Palygin, Mark Chandy, et al.
Acta Physiologica (2024) Vol. 240, Iss. 12
Open Access | Times Cited: 2
Kidney Proximal Tubule GLUT2—More than Meets the Eye
Majdoleen Ahmad, Ifat Abramovich, Bella Agranovich, et al.
Cells (2022) Vol. 12, Iss. 1, pp. 94-94
Open Access | Times Cited: 11
Bibliometric Analysis and Visualization of Research Progress in the Diabetic Nephropathy Field from 2001 to 2021
Ying Shao, Xiaoguang Shi
Oxidative Medicine and Cellular Longevity (2023) Vol. 2023, pp. 1-16
Open Access | Times Cited: 6
Pharmaceutical targeting of the cannabinoid type 1 receptor impacts the crosstalk between immune cells and islets to reduce insulitis in humans
Elise Wreven, María Soledad Ruiz de Adana, Stéphan Hardivillé, et al.
Diabetologia (2024) Vol. 67, Iss. 9, pp. 1877-1896
Open Access | Times Cited: 2
Increasing glutathione levels by a novel posttranslational mechanism inhibits neuronal hyperexcitability
Ashwini Sri Hari, Rajeswari Banerji, Liping Liang, et al.
Redox Biology (2023) Vol. 67, pp. 102895-102895
Open Access | Times Cited: 6
Cannabinoid Signaling in Kidney Disease
Liana Arceri, Thanh Khoa Nguyen, Shannon Gibson, et al.
Cells (2023) Vol. 12, Iss. 10, pp. 1419-1419
Open Access | Times Cited: 5
Renal Endocannabinoid Dysregulation in Obesity-Induced Chronic Kidney Disease in Humans
Anna Permyakova, Ariel Rothner, Sarah Knapp, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13636-13636
Open Access | Times Cited: 5
Targeting DNA methylation in diabetic kidney disease: A new perspective
Vivek Akhouri, Syamantak Majumder, Anil Bhanudas Gaikwad
Life Sciences (2023) Vol. 335, pp. 122256-122256
Closed Access | Times Cited: 3
Genetic Tools in Rodents to Study Cannabinoid Functions
Krisztina Monory, Iñigo Ruı́z de Azúa, Beat Lutz
Current topics in behavioral neurosciences (2024)
Closed Access
mTORC1 under the control of CB1R
Monica Wang
Nature Reviews Nephrology (2022) Vol. 18, Iss. 6, pp. 345-345
Closed Access
Cannabinoid Signaling in the Diabetic Proximal Tubule: Of Mice and Men
Abhijit S. Naik, Frank C. Brosius
American Journal of Kidney Diseases (2022) Vol. 81, Iss. 1, pp. 110-113
Open Access
Page 1

Scroll to top